Ossiam’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.93M | Buy |
+50,862
| New | +$2.92M | 0.04% | 229 |
|
|
2025
Q4 | – | Sell |
-51,042
| Closed | -$2.3M | – | 400 |
|
|
2025
Q3 | $2.3M | Buy |
51,042
+7,781
| +18% | +$363K | 0.03% | 317 |
|
|
2025
Q2 | $2M | Sell |
43,261
-8,472
| -16% | -$416K | 0.02% | 274 |
|
|
2025
Q1 | $3.16M | Buy |
51,733
+2,100
| +4% | +$122K | 0.04% | 175 |
|
|
2024
Q4 | $2.81M | Sell |
49,633
-10,336
| -17% | -$578K | 0.05% | 200 |
|
|
2024
Q3 | $3.1M | Sell |
59,969
-30,015
| -33% | -$1.41M | 0.06% | 151 |
|
|
2024
Q2 | $3.74M | Buy |
89,984
+1,801
| +2% | +$80.6K | 0.07% | 143 |
|
|
2024
Q1 | $4.78M | Buy |
88,183
+21,234
| +32% | +$1.08M | 0.08% | 142 |
|
|
2023
Q4 | $3.44M | Sell |
66,949
-22,440
| -25% | -$1.18M | 0.06% | 156 |
|
|
2023
Q3 | $5.19M | Buy |
89,389
+18,315
| +26% | +$1.12M | 0.09% | 116 |
|
|
2023
Q2 | $4.55M | Buy |
71,074
+1,758
| +3% | +$118K | 0.08% | 139 |
|
|
2023
Q1 | $4.8M | Sell |
69,316
-4,075
| -6% | -$287K | 0.1% | 133 |
|
|
2022
Q4 | $5.28M | Sell |
73,391
-778
| -1% | -$58.7K | 0.14% | 110 |
|
|
2022
Q3 | $5.27M | Sell |
74,169
-22,362
| -23% | -$1.62M | 0.15% | 113 |
|
|
2022
Q2 | $7.43M | Sell |
96,531
-105,467
| -52% | -$8.03M | 0.22% | 80 |
|
|
2022
Q1 | $14.8M | Buy |
201,998
+118,924
| +143% | +$7.99M | 0.39% | 55 |
|
|
2021
Q4 | $5.18M | Sell |
83,074
-67,250
| -45% | -$3.94M | 0.14% | 129 |
|
|
2021
Q3 | $8.89M | Sell |
150,324
-338,788
| -69% | -$22.3M | 0.25% | 69 |
|
|
2021
Q2 | $33.2M | Buy |
489,112
+339,269
| +226% | +$22.1M | 0.9% | 28 |
|
|
2021
Q1 | $9.46M | Buy |
149,843
+82,351
| +122% | +$5.12M | 0.29% | 65 |
|
|
2020
Q4 | $4.19M | Sell |
67,492
-31,082
| -32% | -$1.91M | 0.15% | 113 |
|
|
2020
Q3 | $5.94M | Sell |
98,574
-17,644
| -15% | -$1.06M | 0.25% | 61 |
|
|
2020
Q2 | $6.83M | Sell |
116,218
-13,611
| -10% | -$814K | 0.44% | 47 |
|
|
2020
Q1 | $7.24M | Buy |
129,829
+65,095
| +101% | +$3.98M | 0.49% | 46 |
|
|
2019
Q4 | $4.16M | Buy |
64,734
+16,748
| +35% | +$959K | 0.32% | 65 |
|
|
2019
Q3 | $2.43M | Buy |
47,986
+26,987
| +129% | +$1.27M | 0.17% | 104 |
|
|
2019
Q2 | $952K | Buy |
20,999
+6,979
| +50% | +$325K | 0.07% | 154 |
|
|
2019
Q1 | $669K | Sell |
14,020
-44,289
| -76% | -$2.21M | 0.06% | 156 |
|
|
2018
Q4 | $3.03M | Buy |
+58,309
| New | +$3.13M | 0.46% | 65 |
|
Other funds holding BMY
Ossiam's BMY Position: Q2 2026 in Review
Ossiam opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 50,862 shares worth $2.93M. The stake represents 0.04% of the portfolio and ranks #229 among its holdings. This is a return to the name: Ossiam previously reported a position in BMY as recently as Q3 2025.
Ossiam first reported a position in BMY in Q4 2018 and has held it in 29 quarters since. The position peaked at $33.2M in Q2 2021. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Ossiam held 50,862 shares of Bristol-Myers Squibb worth $2.93M as of Q2 2026.
- Bristol-Myers Squibb was a new Ossiam position in Q2 2026.
- Bristol-Myers Squibb made up 0.04% of Ossiam's portfolio in Q2 2026, its #229 holding.
- Ossiam first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 29 quarters since.
- Ossiam's Bristol-Myers Squibb position peaked at $33.2M in Q2 2021.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.